Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuesaitong soft capsules for ischemic stroke
ChiCTR1800016363Phase 4Completed
- Sponsor
- Xuanwu Hospital
- Start
- Nov 2017
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of panax notoginseng in ischemic stroke (2 arms), sponsored by Xuanwu Hospital. Primary endpoints: Proportion of good functional outcome and Proportion of serious adverse events. Started Nov 2017; status: completed.
02
Drugs
panax notoginseng
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1800016363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016363.